1. Home
  2. APOG vs ORGO Comparison

APOG vs ORGO Comparison

Compare APOG & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

APOG

Apogee Enterprises Inc.

HOLD

Current Price

$38.54

Market Cap

835.9M

ML Signal

HOLD

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

HOLD

Current Price

$2.86

Market Cap

514.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APOG
ORGO
Founded
1949
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
835.9M
514.0M
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
APOG
ORGO
Price
$38.54
$2.86
Analyst Decision
Strong Buy
Buy
Analyst Count
1
3
Target Price
$47.00
$7.67
AVG Volume (30 Days)
146.4K
554.3K
Earning Date
04-09-2026
05-29-2026
Dividend Yield
2.74%
N/A
EPS Growth
N/A
1600.00
EPS
1.74
0.15
Revenue
$1,360,994,000.00
$564,169,000.00
Revenue This Year
$4.12
N/A
Revenue Next Year
N/A
$10.07
P/E Ratio
$22.63
$19.83
Revenue Growth
N/A
17.04
52 Week Low
$30.75
$2.61
52 Week High
$48.79
$7.08

Technical Indicators

Market Signals
Indicator
APOG
ORGO
Relative Strength Index (RSI) 40.07 25.18
Support Level $37.52 $2.61
Resistance Level $38.52 $3.28
Average True Range (ATR) 1.24 0.23
MACD -0.38 -0.08
Stochastic Oscillator 17.08 4.14

Price Performance

Historical Comparison
APOG
ORGO

About APOG Apogee Enterprises Inc.

Apogee Enterprises Inc is a provider of architectural products and services for enclosing buildings, and high-performance glass and acrylic products used in applications for preservation, protection, and enhanced viewing. The company's operating segment consists of the Architectural Metals Segment, Architectural Services Segment, Architectural Glass Segment, and Performance Surfaces Segment. The company generates the majority of its revenue from the Architectural Metals Segment, which designs, engineers, fabricates, and finishes aluminum window, curtainwall, storefront, and entrance systems used principally in non-residential construction. The company generates revenue geographically from the United States, Canada, and Brazil, with the majority coming from the United States.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: